BE579299A - - Google Patents

Info

Publication number
BE579299A
BE579299A BE579299DA BE579299A BE 579299 A BE579299 A BE 579299A BE 579299D A BE579299D A BE 579299DA BE 579299 A BE579299 A BE 579299A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of BE579299A publication Critical patent/BE579299A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/04Processes using organic exchangers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/44Preparation of metal salts or ammonium salts
BE579299D 1958-06-04 BE579299A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US739668A US3027303A (en) 1958-06-04 1958-06-04 Hematinic compositions

Publications (1)

Publication Number Publication Date
BE579299A true BE579299A (de)

Family

ID=24973300

Family Applications (1)

Application Number Title Priority Date Filing Date
BE579299D BE579299A (de) 1958-06-04

Country Status (4)

Country Link
US (1) US3027303A (de)
BE (1) BE579299A (de)
FR (2) FR1304002A (de)
GB (1) GB865836A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR27M (fr) * 1960-07-11 1961-01-06 Therapie Energetique Lab De Nouveaux médicaments anti-hypokaliémiques.
SE351366B (de) * 1965-06-08 1972-11-27 Teikoku Hormone Mfg Co Ltd
US3965133A (en) * 1972-10-04 1976-06-22 Astra Lakemedel Aktiebolag Polymer
DE2344884C3 (de) * 1973-09-06 1980-08-14 Gewerkschaft Victor Chemische Werke, 4620 Castrop-Rauxel Depot-Tablette für Saugferkel zur Prophylaxe gegen Mangelerscheinungen
IT1186787B (it) * 1985-11-06 1987-12-16 Mediolanum Farmaceutici Srl Ferro-derivati della globina e dell'acetilglobina dotati di elevata biodisponibilita',processo di preparazione e composizioni farmaceutiche
US5487888A (en) * 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
DE4426154C1 (de) * 1994-07-23 1995-11-02 Karlsruhe Forschzent Ionenaustauscher in Granulatform mit paramagnetischen Eigenschaften und Verfahren zur Abtrennung von Metallionen
DE10016041A1 (de) * 2000-03-31 2001-10-04 Stockhausen Chem Fab Gmbh Pulverförmige an der Oberfläche vernetzte Polymerisate
DE50102334D1 (de) 2000-03-31 2004-06-24 Stockhausen Chem Fab Gmbh Pulverförmige, an der oberfläche vernetzte polymerisate
US8287848B2 (en) * 2006-10-03 2012-10-16 Tris Pharma Inc Formulations containing an ionic mineral-ion exchange resin complex and uses thereof
US7816404B2 (en) * 2007-07-20 2010-10-19 Rockwell Medical Technologies, Inc. Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB572229A (en) * 1942-02-25 1945-09-28 Courtaulds Ltd Improvements in and relating to the removal of metals from solutions thereof
US2498687A (en) * 1945-11-01 1950-02-28 Delmar H Larsen Vasoconstrictor composition
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
US2820740A (en) * 1953-02-27 1958-01-21 Benger Lab Ltd Therapeutic preparations of iron
US2764518A (en) * 1953-09-30 1956-09-25 Rohm & Haas Therapeutic mixture of carboxylic cation exchange resin and its copper salt
US2816060A (en) * 1954-07-28 1957-12-10 Abbott Lab Ferrous chelate compositions for oral administration
US2841526A (en) * 1956-06-04 1958-07-01 R J Strasenburgh Co Fatty acid-resin adsorption product
US2949366A (en) * 1957-11-22 1960-08-16 Kelco Co Cold milk puddings and method of producing the same

Also Published As

Publication number Publication date
FR324M (fr) 1961-03-20
GB865836A (en) 1961-04-19
US3027303A (en) 1962-03-27
FR1304002A (fr) 1962-09-21

Similar Documents

Publication Publication Date Title
IT602896A (de)
AT214638B (de)
JPS353839Y1 (de)
JPS377013B1 (de)
AT217439B (de)
AT221043B (de)
FR1193882A (de)
AT215747B (de)
FR605M (de)
AT216227B (de)
FR547M (de)
AT213316B (de)
AT213446B (de)
AT215751B (de)
JPS3516511B1 (de)
AT213337B (de)
AT216771B (de)
AT216749B (de)
AT216803B (de)
AT213313B (de)
AT214270B (de)
AT214348B (de)
FR1155924A (de)
AT216831B (de)
AT219868B (de)